PE firm recaps StateServ Medical
By HME News Staff
Updated 9:17 AM CST, Mon November 22, 2021
NEW YORK – WindRose Health Investors, a New York-based private equity firm, has completed the recapitalization of StateServ Medical, a provider of DME benefit management solutions to the post-acute care market. WindRose partnered with StateServ’s executive team to recapitalize the business and to provide additional capital to support future growth, accelerating the next phase of the company’s expansion. "We are excited to partner with WindRose as StateServ enters its next phase of growth," said Paul DiCosmo, StateServ's CEO and co-founder. "We believe that our partnership with WindRose will further empower us to continue to drive meaningful value for our customers while developing additional solutions to address the complex needs of the post-acute care community and their patients. With the post-acute care industry at an inflection point, we believe that WindRose's experience and relationships will help us to capitalize on the opportunities that are ahead of us." Through a national network of 2,300 DME provider locations and 34 company owned direct service locations, StateServ offers a technology enabled DME cost containment solution to more than 600 customers in the hospice, PACE and skilled-nursing markets. Terms of the transaction were not disclosed.
Comments